Cytomegalovirus Retinitis Completed Phase 2 Trials for Ganciclovir (DB01004)

Also known as: CMV retinitis / Cytomegaloviral retinitis (disorder) / Cytomegalovirus chorioretinitis / Chorioretinitis caused by Cytomegalovirus (disorder)

IndicationStatusPhase
DBCOND0000283 (Cytomegalovirus Retinitis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00002156A Randomized Comparison of Intravitreal ISIS 2922 Plus Ganciclovir Versus Ganciclovir as Treatment for Patients With Cytomegalovirus Retinitis ( CMVR )Treatment
NCT00001034The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVTreatment
NCT00001061Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDSTreatment
NCT00000766CMV Retinitis Retreatment TrialTreatment